The market for autoimmune disease therapeutics is expected to grow at a compound annual growth rate (CAGR) of approximately 12.9% from USD 54.8 billion in 2021 to USD 113.48 billion by 2028.
Autoimmune Disease Therapeutics Market: Overview
Autoimmune diseases are caused by an autoimmune response that attacks cells and destroys body tissue. Autoimmune disorders are almost always fatal and have no long-term cure. There are approximately 80 autoimmune conditions with unknown aetiology worldwide. This disease affects over 300 million people worldwide, with women constituting 70-80% of those affected. The two main factors driving market growth are increased awareness of these issues and the rising prevalence of autoimmune diseases.
Read Related:
https://www.zionmarketresearch.com/news/global-autoimmune-disease-therapeutics-market
Autoimmune Disease Therapeutics Market: Dynamics
As the prevalence of autoimmune diseases increased, so did patient awareness, and laboratory automation enabled the simultaneous diagnosis of multiple diagnostic tests, resulting in faster and more accurate results. All of these factors contributed to the growth of the global market for autoimmune disease therapies. As a result, the market is growing. As a result of the autoimmune disease, healthy tissues, cells, and organs are destroyed. Any part of the body can be affected, impairing function and threatening life.
Market Segmentation for Autoimmune Disease Therapeutics
The global autoimmune disease therapies market is divided into three segments: medicine class, distribution method, and geographic segments.
The most common pharmacological agents are immunosuppressants, anti-inflammatory medications, corticosteroids, nonsteroidal anti-inflammatory drugs, and biologics.
The four distribution channels for the market are independent pharmacies, hospitals, and clinics. Hospital spending is anticipated to increase more quickly during the forecasted timeframe.
Competitive Landscape
Some of the main competitors dominating the global autoimmune disease therapeutics market include – Chugai Pharmaceutical Co. Ltd, Amgen Inc, Eli Lilly and Company, Genentech Inc, Elan Corporation Plc, F. Hoffmann-La Roche AG, Squibb Company, Merck Co. Inc, GlaxoSmithKline Plc, Bayer Schering Pharma AG, Biogen Idec Inc, Johnson Johnson Inc, and Abbott Laboratories.
The global autoimmune disease therapeutics market is divided into the following segments:
By Drug Class
Immunosuppressants
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-Inflammatory Drugs
Biologics
By Distribution Channel
Hospitals
Clinics
Drug Stores
Independent Pharmacies
By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East Africa
GCC
South Africa
Rest of Middle East Africa
Contact US
Zion Market Research
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL-FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
Read Also:
https://www.tumblr.com/newsfacts/710682440922988544/crypto-wallets-market-size-share-growth-and
TECNO ROHIT 